X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
aged (7) 7
female (7) 7
humans (7) 7
male (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
care and treatment (6) 6
multiple myeloma (6) 6
hematology, oncology and palliative medicine (5) 5
multiple myeloma - drug therapy (5) 5
adult (4) 4
analysis (4) 4
bortezomib (4) 4
dexamethasone (4) 4
follow-up studies (4) 4
hematology (4) 4
middle aged (4) 4
oncology (4) 4
patients (4) 4
product development (4) 4
survival (4) 4
survival rate (4) 4
therapy (4) 4
chemotherapy (3) 3
clinical trials (3) 3
dexamethasone - administration & dosage (3) 3
neoplasm staging (3) 3
prognosis (3) 3
proteins (3) 3
steroids (3) 3
thalidomide - administration & dosage (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
aged, 80 and over (2) 2
anemia (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
autografts (2) 2
chemistry (2) 2
corticosteroids (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
drug resistance, neoplasm - drug effects (2) 2
drugs (2) 2
efficient (2) 2
geology (2) 2
geosciences, multidisciplinary (2) 2
health risk assessment (2) 2
immunomodulation (2) 2
intravenous administration (2) 2
kaplan-meier estimate (2) 2
lymphomas (2) 2
mass extinction theory (2) 2
medical colleges (2) 2
medical services (2) 2
medicine, general & internal (2) 2
models, molecular (2) 2
motivation (2) 2
multicenter (2) 2
multidisciplinary sciences (2) 2
multiple myeloma - mortality (2) 2
multiple myeloma - pathology (2) 2
neoplasm recurrence, local - drug therapy (2) 2
neutropenia (2) 2
paleontology (2) 2
peripheral neuropathy (2) 2
permeability (2) 2
pneumonia (2) 2
pyrenees (2) 2
randomization (2) 2
risk (2) 2
risk factors (2) 2
safety (2) 2
salvage therapy (2) 2
spain (2) 2
stem cell transplantation (2) 2
stem cells (2) 2
studies (2) 2
thalidomide (2) 2
thalidomide - analogs & derivatives (2) 2
transplantation (2) 2
urine (2) 2
1800-tallet (1) 1
1st occurrence (1) 1
20th century (1) 1
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (1) 1
acetylcholine - chemistry (1) 1
acetylcholine - secretion (1) 1
actividad politica (1) 1
actividad política (1) 1
adenosine 5'-triphosphate (1) 1
adenosine triphosphate - chemistry (1) 1
adenosine triphosphate - secretion (1) 1
adjustment (1) 1
adults (1) 1
age factors (1) 1
aged patients (1) 1
ainsa basin (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. 241 - 250
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1055 - 1066
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal Article
by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
PLOS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0178022
Journal Article
Organic and Biomolecular Chemistry, ISSN 1477-0520, 01/2012, Volume 10, Issue 2, pp. 431 - 439
Journal Article